Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imke Rudnik-Jansen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 10, 2021
FcRn expression in cancer: Mechanistic basis and therapeutic opportunitiesImke Rudnik-Jansen, Kenneth A Howard
JOR Spine|August 8, 2024
Biomolecular therapies for chronic discogenic low back pain: A narrative reviewImke Rudnik-Jansen, Sanda van Kruining Kodele, Laura Creemers, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 7, 2019
Safety of intradiscal delivery of triamcinolone acetonide by a poly(esteramide) microsphere platform in a large animal model of intervertebral disc degenerationImke Rudnik-Jansen, Anna Tellegen, Martijn Beukers, et al.
Acta Biomaterialia|September 26, 2022
An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extensionElisabeth Fuchs, Imke Rudnik-Jansen, Anders Dinesen, et al.
Drug Delivery|March 8, 2019
Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis modelImke Rudnik-Jansen, Karin Schrijver, Nina Woike, et al.
Pharmaceutics|February 10, 2019
Applicability of a Modified Rat Model of Acute Arthritis for Long-Term Testing of Drug Delivery SystemsImke Rudnik-Jansen, Nina Woike, Suzanne de Jong, et al.
Cells|March 6, 2021
Association between Oncostatin M Expression and Inflammatory Phenotype in Experimental Arthritis Models and Osteoarthritis PatientsJoao Pedro Garcia, Lizette Utomo, Imke Rudnik-Jansen, et al.
Communications Biology|March 9, 2021
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinityOle A Mandrup, Sui Ching Ong, Simon Lykkemark, et al.
Pharmaceutics|April 3, 2021
Intra-Articular Slow-Release Triamcinolone Acetonide from Polyesteramide Microspheres as a Treatment for OsteoarthritisAnna Tellegen, Martijn Beukers, Imke Rudnik-Jansen, et al.
Angewandte Chemie (International Ed. in English)|March 30, 2022
Functionalized Acyclic (l)-Threoninol Nucleic Acid Four-Way Junction with High Stability In Vitro and In VivoAnders Märcher, Vipin Kumar, Veronica L Andersen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 10, 2021
FcRn expression in cancer: Mechanistic basis and therapeutic opportunitiesImke Rudnik-Jansen, Kenneth A Howard
JOR Spine|August 8, 2024
Biomolecular therapies for chronic discogenic low back pain: A narrative reviewImke Rudnik-Jansen, Sanda van Kruining Kodele, Laura Creemers, et al.
The Spine Journal : Official Journal of the North American Spine Society|May 7, 2019
Safety of intradiscal delivery of triamcinolone acetonide by a poly(esteramide) microsphere platform in a large animal model of intervertebral disc degenerationImke Rudnik-Jansen, Anna Tellegen, Martijn Beukers, et al.
Acta Biomaterialia|September 26, 2022
An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extensionElisabeth Fuchs, Imke Rudnik-Jansen, Anders Dinesen, et al.
Drug Delivery|March 8, 2019
Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis modelImke Rudnik-Jansen, Karin Schrijver, Nina Woike, et al.
Pharmaceutics|February 10, 2019
Applicability of a Modified Rat Model of Acute Arthritis for Long-Term Testing of Drug Delivery SystemsImke Rudnik-Jansen, Nina Woike, Suzanne de Jong, et al.
Cells|March 6, 2021
Association between Oncostatin M Expression and Inflammatory Phenotype in Experimental Arthritis Models and Osteoarthritis PatientsJoao Pedro Garcia, Lizette Utomo, Imke Rudnik-Jansen, et al.
Communications Biology|March 9, 2021
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinityOle A Mandrup, Sui Ching Ong, Simon Lykkemark, et al.
Pharmaceutics|April 3, 2021
Intra-Articular Slow-Release Triamcinolone Acetonide from Polyesteramide Microspheres as a Treatment for OsteoarthritisAnna Tellegen, Martijn Beukers, Imke Rudnik-Jansen, et al.
Angewandte Chemie (International Ed. in English)|March 30, 2022
Functionalized Acyclic (l)-Threoninol Nucleic Acid Four-Way Junction with High Stability In Vitro and In VivoAnders Märcher, Vipin Kumar, Veronica L Andersen, et al.
Pageof 2